2-Arachidonoylglycerol and the cannabinoid receptors

Chemistry and Physics of Lipids

Volumn 108, Issue 1-2, 2000, Pages 89-106

  Sugiura, Takayuki ^a   Waku, Keizo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

9 Tetrahydrocannabinol; 2 Arachidonoylglycerol; Anandamide; Cannabinoid; Lysophosphatidic acid; Monoacylglycerol

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CALCIUM ION; CANNABINOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR SUBTYPE;

BIOSYNTHESIS; CALCIUM CURRENT; DEGRADATION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TISSUE LEVEL;

ANIMALS; ARACHIDONIC ACIDS; GLYCERIDES; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0033653297     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(00)00189-4     Document Type: Review

References (104)

1. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid
2. Diglyceride lipase: A pathway for arachidonate release from human platelets
3. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
4. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
5. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
6. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin
7. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina
8. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
9. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
10. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation
11. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
12. Cannabinoids enhance human B-cell growth at low nanomolar concentrations
13. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
14. Production and physiological actions of anandamide in the vasculature of the rat kidney
15. Determination and characterization of a cannabinoid receptor in rat brain
16. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
17. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
18. Cannabinoid pharmacology
19. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
20. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells
21. 2-Arachidonoyl-glycerol as an 'endocannabinoid': Limelight for a formerly neglected metabolite
22. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
23. Biochemistry of the endogenous ligands of cannabinoid receptors
24. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
25. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide
26. Metabolism of anandamide and 2-arachidonoylglycerol: An historical overview and some recent developments
27. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages
28. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
29. Stimulation of mono- and diacylglycerol lipase activities by bradykinin in neural cultures
30. Effect of glutamate and its analogs on diacylglycerol and monoacylglycerol lipase activities of neuron-enriched cultures
31. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones
32. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
33. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat
34. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
35. Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons
36. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
37. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide
38. Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland
39. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand
40. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors
41. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture
42. Early changes in inositol lipids and their metabolites induced by platelet-derived growth factor in quiescent Swiss mouse 3T3 cells
43. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
44. Localization of cannabinoid receptors in brain and periphery
45. Biochemistry and pharmacology of arachidonylethanolamide a putative endogenous cannabinoid
46. Marijuana and immunity
47. Cannabinoid compounds and signal transduction mechanisms
48. Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system
49. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves
50. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice
51. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells
52. Immunological characterization of sn-1,2-diacylglycerol and sn-2-monoacylglycerol kinase from pig brain
53. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue
54. 2+-dependent and -independent mechanisms
55. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor
56. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes
57. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
58. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
59. Molecular biology of the cannabinoid receptor
60. Cannabinoid geometry and biological activity
61. The unpaved road to the endogenous brain cannabinoid ligands, the anandamides
62. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
63. Endocannabinoids
64. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid
65. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
66. Purification and characterization of diacylglycerol lipase from human platelets
67. Molecular characterization of a peripheral receptor for cannabinoids
68. Occurrence of a novel cannabimimetic molecule 2-sciadonoylglycerol (2-eicosa-5',11',14'-trienoylglycerol) in the umbrella pine Sciadopitys verticillata seeds
69. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells
70. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors
71. Endogenous cannabinoid signaling
72. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
73. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate
74. An endogenous cannabinoid as an endothelium-derived vasorelaxant
75. Regulation of phosphoinositide-specific phospholipase C isozymes
76. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
77. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols
78. The purification and properties of monoacylglycerol kinase from bovine brain
79. Swiss 3T3 cells preferentially incorporate sn-2-arachidonoyl monoacylglycerol into sn-1-stearoyl-2-arachidonoyl phosphatidylinositol
80. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats
81. A second endogenous cannabinoid that modulates long-term potentiation
82. Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system
83. Biological activities of N-acylethanolamine and N-acylethanolamine phosphate analogues
84. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: Comparison with platelet activating factor
85. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
86. 2+-dependent transacylase and phosphodiesterase activities
87. 2+ in neuroblastoma x glioma hybrid NG108-15 cells
88. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from freearachidonic acid and ethanolamine
89. Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells
90. 2+ transient in NG108-15 cells
91. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator
92. Biosynthesis and actions of anandamide and 2-arachidonoylglycerol: Two endogenous cannabimimetic molecules
93. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells
94. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
95. Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain
96. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
97. Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues
98. A family of phospholipid autacoids: Occurrence, metabolism and bioactions
99. Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes
100. A lysophosphoinositide-specific phospholipase C distinct from other phospholipase C families in rat brain
101. A possible pathway of phosphoinositide metabolism through EDTA-insensitive phospholipase A1 followed by lysophosphoinositide-specific phospholipase C in rat brain
102. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide
103. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension